1. Home
  2. LTH vs KRYS Comparison

LTH vs KRYS Comparison

Compare LTH & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Life Time Group Holdings Inc.

LTH

Life Time Group Holdings Inc.

HOLD

Current Price

$25.56

Market Cap

5.5B

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$233.88

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTH
KRYS
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.3B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
LTH
KRYS
Price
$25.56
$233.88
Analyst Decision
Buy
Strong Buy
Analyst Count
11
9
Target Price
$37.50
$214.22
AVG Volume (30 Days)
2.0M
274.5K
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
88.46
275.72
EPS
1.28
6.66
Revenue
$2,913,442,000.00
$373,164,000.00
Revenue This Year
$15.07
$36.14
Revenue Next Year
$10.88
$41.80
P/E Ratio
$19.93
$35.13
Revenue Growth
15.77
54.51
52 Week Low
$21.49
$122.80
52 Week High
$34.99
$241.20

Technical Indicators

Market Signals
Indicator
LTH
KRYS
Relative Strength Index (RSI) 45.04 80.39
Support Level $24.46 $213.83
Resistance Level $27.11 $221.84
Average True Range (ATR) 0.68 7.76
MACD 0.01 1.37
Stochastic Oscillator 32.48 79.71

Price Performance

Historical Comparison
LTH
KRYS

About LTH Life Time Group Holdings Inc.

Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: